AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
AstraZeneca HK, Lippo Healthcare partner for health innovation in GBA
The collaboration will address healthcare challenges in treating chronic diseases.
Most Read
1. US foreign aid cuts pressure health systems in emerging markets 2. Packaging with purpose: IPP Malaysia sets new industry benchmark with a win at the 2025 Malaysia National Business Awards 3. Majority of businesses eye increasing electricification efforts in three years 4. Business partnership as TKDN services: Unlocking Indonesia’s digital future 5. In vitro diagnostics to be valued at $141.9b by 2029Resource Center
Read Here
Advertise
Sign Up
Awards
Sep
25
Sep
25
Event News
Asian Management Excellence Awards 2025 Winner: Norimah Judin and Dk Rodzi Pg Hj Abd Rahman of BIBD
Norimah Judin and Dk Rodzi Pg Hj Abd Rahman of BIBD share how their BIBD Wellness Ambassadors initiative won at the Asian Management Excellence Awards 2025.
Commentary
Business partnership as TKDN services: Unlocking Indonesia’s digital future
Are luxury boutique hotels the new black?